Phase I/II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN).

被引：0
|
作者：
Herchenhorn, D.
Dias, F. L.
Ferreira, C. G.
Bezerra, M.
Fonseca, A. J.
Mora, P.
Pineda, R. M.
Fontao, K.
Knust, R. E.
Martins, R. G.
机构：
[1] Inst Nacl Canc, Rio De Janeiro, Brazil
[2] Univ Washington, Seattle, WA 98195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：298S / 298S
页数：1
相关论文
共 50 条
  • [31] Phase I study of the EGFR tyrosine kinase inhibitor erlotinib in combination with docetaxel and radiation in locally advanced squamous cell cancer of the head and neck (SCCHN).
    Savvides, P.
    Agarwala, S. S.
    Greskovich, J.
    Argiris, A.
    Bokar, J.
    Cooney, M.
    Hoppel, C.
    Stepnick, D. W.
    Lavertu, P.
    Remick, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 291S - 291S
  • [32] Phase I study of cabazitaxel-PF induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Khan, Adnan
    Babu, Rita
    Vaz, Amiya
    Deyne-Borza, Michele
    Price, Alicia
    Bakst, Richard Lorne
    Gupta, Vishal
    Miles, Brett
    Posner, Marshall R.
    Misiukiewicz, Krzysztof
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
    Jacinto, Alexandre Arthur
    Batalha Filho, Eronides Salustiano
    Viana, Luciano de Souza
    De Marchi, Pedro
    Capuzzo, Renato de Castro
    Gama, Ricardo Ribeiro
    Boldrini Junior, Domingos
    Santos, Carlos Roberto
    Junqueira Pinto, Gustavo Dix
    Dias, Josiane Mourao
    Canton, Heloisa Pelisser
    Carvalho, Raiany
    Radicchi, Lucas Augusto
    Bentzen, Soren
    Zubizarreta, Eduardo
    Carvalho, Andre Lopes
    BMC CANCER, 2018, 18
  • [34] Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
    Alexandre Arthur Jacinto
    Eronides Salustiano Batalha Filho
    Luciano de Souza Viana
    Pedro De Marchi
    Renato de Castro Capuzzo
    Ricardo Ribeiro Gama
    Domingos Boldrini Junior
    Carlos Roberto Santos
    Gustavo Dix Junqueira Pinto
    Josiane Mourão Dias
    Heloisa Pelisser Canton
    Raiany Carvalho
    Lucas Augusto Radicchi
    Soren Bentzen
    Eduardo Zubizarreta
    Andre Lopes Carvalho
    BMC Cancer, 18
  • [35] Preliminary report of phase II study of neoadjuvant chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in locally advanced squamous cell carcinoma of the head and neck cancer (SCCHN) patients
    Chitapanarux, I.
    Lorvidhaya, V.
    Tharavichitkul, E.
    Sittitrai, R.
    Pattarasakulchai, I.
    Kamnerdsupaphon, P.
    Sukthomyal, V.
    EJC SUPPLEMENTS, 2005, 3 (02): : 311 - 312
  • [36] A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma
    Tao, Yungan
    Rezai, Keyvan
    Brain, Etienne
    Etessami, Atoussa
    Lusinchi, Antoine
    Temam, Stephane
    Urien, Sail
    Van, Marie-Louise Vo
    Vauzelle-Kervroedan, Francoise
    Lokiec, Francois
    Daly-Schveitzer, Nicolas
    Bourhis, Jean
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 (01) : 42 - 47
  • [37] Phase I/II study of docetaxel, cisplatin and S-1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma
    Tada, Yuichiro
    Maruya, Shin-Ichiro
    Saotome, Takashi
    Miura, Kouki
    Masubuchi, Tatsuo
    Fushimi, Chihiro
    Okamoto, Isaku
    Takeishi, Etsuro
    Yamada, Shuhei
    Asai, Hiroaki
    Kamata, Shin-Etsu
    ONCOLOGY LETTERS, 2012, 4 (05) : 898 - 904
  • [38] Cisplatin or Carboplatin in locally advanced head and neck squamous cell carcinoma
    Eldin, N. Bahie
    Mosalem, N.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 37 - 37
  • [39] Concomitant low-dose cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN): Analysis of survival and toxicity.
    Lau, H
    Yee, D
    Mackinnon, J
    Brar, S
    Hao, D
    Gluck, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 501S - 501S
  • [40] A phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinoma
    Ang, Mei-Kim
    Montoya, Jose Enrique
    Tharavichitkul, Ekkasit
    Lim, Cindy
    Tan, Terence
    Wang, Lan Ying
    Wee, Joseph
    Soong, Yoke-Lim
    Fong, Kam-Weng
    Ng, Quan Sing
    Tan, Daniel Shao-Weng
    Toh, Chee-Keong
    Tan, Eng-Huat
    Lim, Wan-Teck
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (05): : 1641 - 1651
12345